ZTS

NYSE · Pharmaceuticals

Zoetis Inc

S&P 500 Large-Cap Stocks Blue Chip Stocks Pharmaceutical Stocks Healthcare Stocks Best Dividend Stocks

$82.11

-7.09 (-7.95%)

As of Nov 5, 9:35 PM ET ·

Analyst Consensus

Hold

Analysts

High

Coverage

Buy 11 48%

Hold 12 52%

Sell 0 0%

Price Target

Analyst Price Target +155.6% upside

Low Target $137.04

Average Target $209.87

High Target $267.95

Current Price $82.11

Current
$82.11

Target
$209.87

$137.04 $209.87 avg $267.95

Scenario Analysis

Bear Case

$137.04

66.9%

Low target

Base Case

$209.87

+155.6%

Avg target

Bull Case

$267.95

+226.3%

High target

Risk/Reward

3.4x

Highly favorable

Price in Context

52-Week High

$146.11

-43.8% from high

52-Week Low

$68.77

+19.4% from low

50-Day SMA

$75.51

+8.7% vs SMA

200-Day SMA

$92.94

-11.7% vs SMA

RSI (14)

76.4

Overbought

Target vs 52W High

$209.87

+43.6% vs high

Peer Consensus — Pharmaceuticals

Stock	Consensus	Analysts	Buy %	Target	Upside
LLY Eli Lilly and Co.	Strong Buy	36	86%	$1,330.33	-2.5%
RDY Dr. Reddy's Laboratories	Sell	42	45%	—	+0.0%
JNJ Johnson & Johnson	Buy	30	73%	$299.55	+10.0%
MRK Merck & Co. Inc.	Buy	35	74%	$159.27	+8.4%
PFE Pfizer Inc.	Hold	33	39%	$33.90	+13.5%
BMY Bristol-Myers Squibb Co	Hold	34	44%	$174.50	+176.4%
RPRX Royalty Pharma Plc- Cl A	Strong Buy	14	93%	$36.26	-46.3%
ZTS Zoetis Inc	Hold	23	48%	$209.87	+155.6%